猴痘病毒DNA聚合酶全酶结构及抑制剂研究

参考文献ADDINZOTERO_BIBL{"uncited":[],"omitted":[],"custom":[]}CSL_BIBLIOGRAPHY[1] CDC.OngoingCladeIIMpoxGlobalOutbreak[EB/OL].(2025-01-31)[2025-05-14]./mpox/outbreaks/2022/index-1.html.[2] KOZLOVM.Monkeypoxgoesglobal:whyscientistsareonalert[J].Nature,2022,606(7912):15-16.[3] SHCHELKUNOVSN,GAVRILOVAEV,BABKINIV.MultiplexPCRdetectionandspeciesdifferentiationoforthopoxvirusespathogenictohumans[J].MolecularandCellularProbes,2005,19(1):1-8.[4] LIKOSAM,SAMMONSSA,OLSONVA,等.Ataleoftwoclades:monkeypoxviruses[J].TheJournalofGeneralVirology,2005,86(Pt10):2661-2672.[5] ISIDROJ,BORGESV,PINTOM,等.Phylogenomiccharacterizationandsignsofmicroevolutioninthe2022multi-countryoutbreakofmonkeypoxvirus[J].NatureMedicine,2022,28(8):1569-1572.[6] BUNGEEM,HOETB,CHENL,等.Thechangingepidemiologyofhumanmonkeypox-Apotentialthreat?Asystematicreview[J].PLoSneglectedtropicaldiseases,2022,16(2):e0010141.[7] OGOINAD,IROEZINDUM,JAMESHI,等.ClinicalCourseandOutcomeofHumanMonkeypoxinNigeria[J].ClinicalInfectiousDiseases:AnOfficialPublicationoftheInfectiousDiseasesSocietyofAmerica,2020,71(8):e210-e214.[8] BEEREM,RAOVB.Asystematicreviewoftheepidemiologyofhumanmonkeypoxoutbreaksandimplicationsforoutbreakstrategy[J].PLoSneglectedtropicaldiseases,2019,13(10):e0007791.[9] FINEPE,JEZEKZ,GRABB,等.Thetransmissionpotentialofmonkeypoxvirusinhumanpopulations[J].InternationalJournalofEpidemiology,1988,17(3):643-650.[10] BREMANJG,KALISA-RUTInull,STENIOWSKIMV,等.Humanmonkeypox,1970-79[J].BulletinoftheWorldHealthOrganization,1980,58(2):165-182.[11] DAMONIK.Statusofhumanmonkeypox:clinicaldisease,epidemiologyandresearch[J].Vaccine,2011,29Suppl4:D54-59.[12] HEYMANNDL,SZCZENIOWSKIM,ESTEVESK.Re-emergenceofmonkeypoxinAfrica:areviewofthepastsixyears[J].BritishMedicalBulletin,1998,54(3):693-702.[13] HUTINYJ,WILLIAMSRJ,MALFAITP,等.Outbreakofhumanmonkeypox,DemocraticRepublicofCongo,1996to1997[J].EmergingInfectiousDiseases,2001,7(3):434-438.[14] REEDKD,MELSKIJW,GRAHAMMB,等.ThedetectionofmonkeypoxinhumansintheWesternHemisphere[J].TheNewEnglandJournalofMedicine,2004,350(4):342-350.[15] SALETA,MELSKIJW,STRATMANEJ.Monkeypox:anepidemiologicandclinicalcomparisonofAfricanandUSdisease[J].JournaloftheAmericanAcademyofDermatology,2006,55(3):478-481.[16] EREZN,ACHDOUTH,MILROTE,等.DiagnosisofImportedMonkeypox,Israel,2018[J].EmergingInfectiousDiseases,2019,25(5):980-983.[17] NGOT,LEEV,MARIMUTHUK,等.AcaseofimportedMonkeypoxinSingapore[J].TheLancet.InfectiousDiseases,2019,19(11):1166.[18] LUMFM,TORRES-RUESTAA,TAYMZ,等.Monkeypox:diseaseepidemiology,hostimmunityandclinicalinterventions[J].NatureReviews.Immunology,2022,22(10):597-613.[19] CZARNECKIMW,TRAKTMANP.ThevacciniavirusDNApolymeraseanditsprocessivityfactor[J].VirusResearch,2017,234:193-206.[20] GRESETHMD,TRAKTMANP.TheLifeCycleoftheVacciniaVirusGenome[J].AnnualReviewofVirology,2022,9(Volume9,2022):239-259.[21] LIY,SHENY,HUZ,等.StructuralbasisfortheassemblyoftheDNApolymeraseholoenzymefromamonkeypoxvirusvariant[J].ScienceAdvances,2023,9(16):eadg2331.[22] BERSCHB,TARBOURIECHN,BURMEISTERWP,等.SolutionStructureoftheC-terminalDomainofA20,theMissingBrickfortheCharacterizationoftheInterfacebetweenVacciniaVirusDNAPolymeraseanditsProcessivityFactor[J].JournalofMolecularBiology,2021,433(13):167009.[23] SÈLEC,GABELF,GUTSCHEI,等.Low-resolutionstructureofvacciniavirusDNAreplicationmachinery[J].JournalofVirology,2013,87(3):1679-1689.[24] DRUCKSHUDOFSKYAM,SILVERMANJEY,CHATTOPADHYAYD,等.VacciniavirusD4mutantsdefectiveinprocessiveDNAsynthesisretainbindingtoA20andDNA[J].JournalofVirology,2010,84(23):12325-12335.[25] BURMEISTERWP,TARBOURIECHN,FENDERP,等.CrystalStructureoftheVacciniaVirusUracil-DNAGlycosylaseinComplexwithDNA[J].TheJournalofBiologicalChemistry,2015,290(29):17923-17934.[26] XUY,WUY,ZHANGY,等.Cryo-EMstructuresofhumanmonkeypoxviralreplicationcomplexeswithandwithoutDNAduplex[J].CellResearch,2023,33(6):479-482.[27] PENGQ,XIEY,KUAIL,等.StructureofmonkeypoxvirusDNApolymeraseholoenzyme[J].Science(NewYork,N.Y.),2023,379(6627):100-105.[28] BOYLEKA,STANITSAES,GRESETHMD,等.EvaluationoftheRoleoftheVacciniaVirusUracilDNAGlycosylaseandA20ProteinsasIntrinsicComponentsoftheDNAPolymeraseHoloenzyme*[J].JournalofBiologicalChemistry,2011,286(28):24702-24713.[29] STANITSAES,ARPSL,TRAKTMANP.VacciniaVirusUracilDNAGlycosylaseInteractswiththeA20ProteintoFormaHeterodimericProcessivityFactorfortheViralDNAPolymerase*[J].JournalofBiologicalChemistry,2006,281(6):3439-3451.[30] SHABILM,KHATIBMN,BALLALS,等.EffectivenessofTecovirimatinMpoxCases:ASystematicReviewofCurrentEvidence[J].JournalofMedicalVirology,2024,96(12):e70122.[31] EZATAA,ABDULJALILJM,ELGHAREIBAM,等.Thediscoveryofnovelantiviralsforthetreatmentofmpox:isdrugrepurposingtheanswer?[J].ExpertOpiniononDrugDiscovery,2023,18(5):551-561.[32] NGUYENBT,MARCA,SUÑERC,等.Earlyadministrationoftecovirimatshortensthetimetompoxclearanceinamodelofhumaninfection[J].PLoSbiology,2023,21(12):e3002249.[33] DESAIAN,THOMPSONGR,NEUMEISTERSM,等.CompassionateUseofTecovirimatfortheTreatmentofMonkeypoxInfection[J].JAMA,2022,328(13):1348-1350.[34] FINKDL,CALLABYH,LUINTELA,等.ClinicalfeaturesandmanagementofindividualsadmittedtohospitalwithmonkeypoxandassociatedcomplicationsacrosstheUK:aretrospectivecohortstudy[J].TheLancet.InfectiousDiseases,2023,23(5):589-597.[35] WANGJ,SHAHED-AI-MAHMUDM,CHENA,等.AnOverviewofAntiviralsagainstMonkeypoxVirusandOtherOrthopoxviruses[J].JournalofMedicinalChemistry,2023,66(7):4468-4490.[36] SIEGRISTEA,SASSINEJ.AntiviralsWithActivityAgainstMpox:AClinicallyOrientedReview[J].ClinicalInfectiousDiseases:AnOfficialPublicationoftheInfectiousDiseasesSocietyofAmerica,2023,76(1):155-164.[37] BAKERRO,BRAYM,HUGGINSJW.Potentialantiviraltherapeuticsforsmallpox,monkeypoxandotherorthopoxvirusinfections[J].AntiviralResearch,2003,57(1-2):13-23.[38] QUENELLEDC,KERNER.TreatmentofVacciniaandCowpoxVirusInfectionsinMicewithCMX001andST-246[J].Viruses,2010,2(12):2681-2695.[39] SMEEDF,SIDWELLRW,KEFAUVERD,等.Characterizationofwild-typeandcidofovir-resistantstrainsofcamelpox,cowpox,monkeypox,andvacciniaviruses[J].AntimicrobialAgentsandChemotherapy,2002,46(5):1329-1335.[40] MAGEEWC,HOSTETLERKY,EVANSDH.MechanismofinhibitionofvacciniavirusDNApolymerasebycidofovirdiphosphate[J].AntimicrobialAgentsandChemotherapy,2005,49(8):3153-3162.[41] PUBCHEM.Cidofovir[EB/OL].[2025-05-14]./compound/60613.[42] PUBCHEM.Brincidofovir[EB/OL].[2025-05-14]./compound/483477.[43] QUENELLEDC,COLLINSDJ,KERNER.Efficacyofmultiple-orsingle-dosecidofoviragainstvacciniaandcowpoxvirusinfectionsinmice[J].AntimicrobialAgentsandChemotherapy,2003,47(10):3275-3280.[44] TROSTLC,ROSEML,KHOURIJ,等.Theefficacyandpharmacokineticsofbrincidofovirforthetreatmentoflethalrabbitpoxvirusinfection:amodelofsmallpoxdisease[J].AntiviralResearch,2015,117:115-121.[45] XUY,WUY,WUX,等.StructuralbasisofhumanmpoxviralDNAreplicationinhibitionbybrincidofovirandcidofovir[J].InternationalJournalofBiologicalMacromolecules,2024,270:132231.[46] HUSTONJ,CURTISS,EGELUNDEF.Brincidofovir:ANovelAgentfortheTreatmentofSmallpox[J].TheAnnalsofPharmacotherapy,2023,57(10):1198-1206.[47] FAUREE,GALPERINET,CANNESSONO,等.Casereport:Brincidofovir-inducedreversiblesevereacutekidneyinjuryin2solid-organtransplantfortreatmentofcytomegalovirusinfection[J].Medicine,2016,95(44):e5226.[48] EL-HADDADD,ELCHAERF,VANICHANANJ,等.Brincidofovir(CMX-001)forrefractoryandresistantCMVandHSVinfectionsinimmunocompromisedcancerpatients:Asingle-centerexperience[J].AntiviralResearch,2016,134:58-62.[49] GRANTS.Ara-C:CellularandMolecularPharmacology[M/OL]//VANDEWOUDEGF,KLEING.AdvancesinCancerResearch:卷72.AcademicPress,1997:197-233[2025-05-14]./science/article/pii/S0065230X08607034.[50] HUMLOVÁZ,VOKURKAM,ESTEBANM,等.Vacciniavirusinducesapoptosisofinfectedmacrophages[J].TheJournalofGeneralVirology,2002,83(Pt11):2821-2832.[51] TADDIEJA,TRAKTMANP.GeneticcharacterizationofthevacciniavirusDNApolymerase:identificationofpointmutationsconferringaltereddrugsensitivitiesandreducedfidelity[J].JournalofVirology,1991,65(2):869-879.[52] TADD